Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $62.88 -0.29%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 25
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 25
Join SI Premium – FREE
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- TransUnion (TRU) PT Lowered to $82 at UBS
- Shift4 Payments (FOUR) PT Lowered to $56 at StoneX as Iran War Impacts Revenues
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
